Pt Kalbe Farma Tbk.
(OTC) PTKFY
Pt Kalbe Farma Tbk. Financials at a Glance
Market Cap
$2.61B
Revenue (TTM)
$35.37T
Net Income (TTM)
$3.67T
EPS (TTM)
$0.98
P/E Ratio
11.81
Dividend
$0.44
Beta (Volatility)
0.21 (Low)
Dividend
$0.44
Beta (Volatility)
0.21 (Low)
Price
$11.54
Volume
81
Open
$12.55
Price
$11.54
Volume
81
Open
$12.55
Previous Close
$11.54
Daily Range
$11.54 - $12.55
52-Week Range
$10.10 - $21.16
Dividend
$0.44
Beta (Volatility)
0.21 (Low)
Price
$11.54
Volume
81
Open
$12.55
Previous Close
$11.54
Daily Range
$11.54 - $12.55
52-Week Range
$10.10 - $21.16
PTKFY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pt Kalbe Farma Tbk.
Industry
Pharmaceuticals
Sector
Health CareEmployees
12,835
CEO
Bernadette Ruth Setiady
Website
www.kalbe.co.idHeadquarters
Jakarta, 10510, ID
PTKFY Financials
Key Financial Metrics (TTM)
Gross Margin
40%
Operating Margin
13%
Net Income Margin
10%
Return on Equity
16%
Return on Capital
18%
Return on Assets
12%
Earnings Yield
8.47%
Dividend Yield
0.04%
Payout Ratio
44.63%
Stock Overview
Market Cap
$2.61B
Shares Outstanding
226.43M
Volume
81
Short Interest
0.00%
Avg. Volume
111.194
Financials (TTM)
Gross Profit
$14.06T
Operating Income
$4.55T
EBITDA
$5.18T
Operating Cash Flow
$3.27T
Capital Expenditure
$809.87B
Free Cash Flow
$2.46T
Cash & ST Invst.
$4.49T
Total Debt
$297.28B
Pt Kalbe Farma Tbk. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.34T
+11.3%
Gross Profit
$3.50T
+1.7%
Gross Margin
37.47%
N/A
Market Cap
$2.61B
N/A
Market Cap/Employee
$203.49K
N/A
Employees
12,841
N/A
Net Income
$1.03T
+19.9%
EBITDA
$1.39T
+13.2%
Quarterly Fundamentals
Net Cash
$4.19T
-2.8%
Accounts Receivable
$5.90T
+17.6%
Inventory
$6.99T
+7.4%
Long Term Debt
$163.72B
-25.6%
Short Term Debt
$133.56B
-60.6%
Return on Assets
11.94%
N/A
Return on Invested Capital
17.81%
N/A
Free Cash Flow
$836.45B
-15.6%
Operating Cash Flow
$1.09T
-13.1%